MTA and Biodentine in Pulpotomized Primary Molars
Launched by CRISTINA CUADROS · May 1, 2012
Trial Information
Current as of May 29, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- * molars showing:
- • 1. symptomless exposure of vital pulp by caries
- • 2. no clinical or radiographic evidence of pulp degeneration (excessive bleeding from the root canal, internal root resorption, inter-radicular and/or furcal bone destruction)
- • 3. the possibility of proper restoration of the teeth
- • 4. no physiological resorption of more than one-third of the root
- Exclusion Criteria:
- • presence of systemic pathology and any history of allergic reaction to latex, local anaesthetics or to the constituents of the test pulp dressing agents
About Cristina Cuadros
Cristina Cuadros is an esteemed clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative studies. With a strong focus on ethical practices and regulatory compliance, Cristina Cuadros collaborates with a network of healthcare professionals and institutions to design and execute clinical trials that address critical healthcare needs. The organization emphasizes rigorous scientific methodologies and patient-centered approaches, ensuring that all trials are conducted with the utmost integrity and transparency. By fostering collaboration and leveraging cutting-edge technologies, Cristina Cuadros aims to contribute to the development of groundbreaking therapies and enhance the overall quality of care in various therapeutic areas.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sant Cugat Del Vallès, Barcelona, Spain
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials